| 2.09 Delayed Data As of Sep 17 |  -0.03 / -1.42%Today’s Change | 0.60 Today|||52-Week Range 2.90 | +202.99% Year-to-Date |
| Previous close | 2.12 |
| Today’s open | 2.12 |
| Day’s range | 2.08 - 2.15 |
| Volume | 40,455 |
| Average volume (3 months) | 168,287 |
| Market cap | $68.4M |
| Earnings growth (last year) | +45.36% |
| Earnings growth (this year) | +3.06% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +5.35% |
| P/E ratio | NM |
| Price/Sales | 2.19 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| EQEquillium Inc | -0.22 | -5.39% |
| VBIVVBI Vaccines Inc | -0.02 | -2.10% |
| PSTIPluristem Therapeuti... | -0.06 | -1.38% |
| KZRKezar Life Sciences ... | +0.26 | +7.41% |
| Next reporting date | November 18, 2019 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $10.4M |
| Annual profit (last year) | -$32.6M |
| Net profit margin | -312.38% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director James E. Dentzer |
Chief Financial Officer & Treasurer William E. Steinkrauss |
Corporate headquarters Lexington, Massachusetts |
